STREAMEX CORP. Severance Costs
STREAMEX CORP. (STEX) reported Severance Costs of $400 for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2026-03-31
- STREAMEX CORP. severance costs for the quarter ending 2025-06-30 was $400.00, a 99.90% decline year-over-year.
- STREAMEX CORP. severance costs for the quarter ending 2024-12-31 was $399.60K.
- STREAMEX CORP. severance costs for the quarter ending 2024-09-30 was -$399.60K.
- STREAMEX CORP. severance costs for the quarter ending 2024-06-30 was $400.00K.
- STREAMEX CORP. severance costs for fiscal 2024 was $400.00K.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|
| 2025-06-30 | $400.00 10-Q · filed 2025-08-15 | |||
| 2024-12-31 | $399.60K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $400.00K derived: sum of 3 quarters · filed 2026-03-31 | $400.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$399.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $400.00 derived: sum of 2 quarters · filed 2025-11-14 | $400.00 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $400.00K 10-Q · filed 2025-08-15 | $400.00K 10-Q · filed 2025-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |